GrantForecasted — not yet open✓ Small businesses may apply
Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
National Institutes of Health
- Opportunity #
- PAR-26-132
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.866
- Status
- forecasted
- Posted
- Mar 4, 2026
- Funding instrument
- Cooperative Agreement
- Category
- Health
- Cost sharing required
- No
Who can apply
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Private institutions of higher education
- •Small businesses
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •For profit organizations other than small businesses
- •Native American tribal governments (Federally recognized)
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •Special district governments
- •County governments
- •Public and State controlled institutions of higher education
- •City or township governments
- •State governments
- •Independent school districts
- •Public housing authorities/Indian housing authorities
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Contact
NIA Scientific Contact · NIA-NOFO-Scientific@nih.gov